USITC Decision: Extension of Deadline for E-Cigarette Investigation

Sep.02.2024
USITC Decision: Extension of Deadline for E-Cigarette Investigation
USITC extends deadline for investigation into disposable e-cigarette devices, impacting 25 companies, with final ruling expected by 2025.

On August 29th, the United States International Trade Commission (USITC) announced its decision not to review the preliminary ruling (Order No. 37) issued by the Chief Administrative Law Judge (CALJ) on July 31, 2024. This ruling extends the target completion date of the investigation to September 29, 2025.


The U.S. International Trade Commission (USITC) has decided not to review the Chief Administrative Law Judge's (CALJ) preliminary ruling (Order No. 37) issued on July 31, 2024, pursuant to Section 337 of the 1930 Tariff Act (19 U.S.C. 1337) and the Commission's rules (19 CFR Part 210), extending the target completion date of the current investigation to September 29, 2025. The purpose of this extension is to avoid scheduling conflicts with other investigations, therefore the final determination will not be made until May 29, 2025.


This investigation stemmed from a complaint filed on December 15, 2023 by R.J. Reynolds Tobacco Company and R.J. Reynolds Vapor Company, alleging that certain disposable e-cigarette devices and their components and packaging violated Section 337 of the Smoot-Hawley Tariff Act of 1930 due to false advertising, false country of origin labeling, and unfair competition practices, severely harming the domestic industry in the United States. A total of 25 companies are being investigated, including tobacco and e-cigarette related companies in the United States, Shenzhen, and other regions. On June 13, 2024, the committee approved the addition of four more companies to be investigated.


The committee's final decision will be announced before September 29, 2025, and the investigation results could have a profound impact on the relevant markets and companies.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
A new Australian study found flavored nicotine e-cigarettes are three times more effective than gum or lozenges for quitting smoking. The trial of 1,000 smokers on government support showed higher quit rates with vaping, but long-term health risks remain unclear.
Jul.17 by 2FIRSTS.ai
Singapore Steps Up Vape Crackdown After National Day, 18 Arrested in Two-Day HSA Operation
Singapore Steps Up Vape Crackdown After National Day, 18 Arrested in Two-Day HSA Operation
The Health Sciences Authority (HSA) of Singapore conducted a two-day enforcement operation, seizing 82 e-vaporiser devices and arresting 18 individuals. The move follows Prime Minister Lawrence Wong’s announcement that vaping will be treated as a drug issue, with some devices found to contain dangerous substances such as etomidate and ketamine.
Aug.21 by 2FIRSTS.ai
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada stated that one year ago, the government removed the nicotine pouch ZONNIC from convenience stores, restricting sales to behind-the-counter in pharmacies. This move caused ZONNIC sales to plummet, cigarette sales to rebound by 2.8%, and was accompanied by a surge of high-dose illegal nicotine pouches and black-market cigarettes (exceeding 500 million packs annually). The company is calling for an evidence-based harm reduction approach to restore multi-channel supply throu
Aug.20 by 2FIRSTS.ai
Jerome Abelman to Step Down as General Counsel of British American Tobacco After 23-Year Career; Paul McCrory Named as Successor
Jerome Abelman to Step Down as General Counsel of British American Tobacco After 23-Year Career; Paul McCrory Named as Successor
British American Tobacco (BAT) has announced that Legal Director and General Counsel Jerome Abelman will leave in late 2025 after 23 years. He will be succeeded in 2026 by Paul McCrory, the current Director of Corporate and Regulatory Affairs. CEO Tadeu Marroco commended Abelman’s service and stated the transition supports the group’s strategic priorities.
Sep.12 by 2FIRSTS.ai
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai
Schaghticoke Fair tobacco booth cited for selling flavored e-cigarettes, violating state laws
Schaghticoke Fair tobacco booth cited for selling flavored e-cigarettes, violating state laws
At the Schaghticoke Fair in the US, a tobacco vendor was investigated for selling flavored e-cigarettes. The inspection revealed multiple violations, including failure to display a “Minimum Age 21” sign and failure to post a retail dealer certificate or certificate of registration for tobacco products. According to state law, these flavored e-cigarettes are prohibited from being sold in retail storefronts. The products have been seized pending a hearing and possible penalties.
Sep.02 by 2FIRSTS.ai